Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A health care worker receives a dose of Pfizer-BioNTech Covid-19 vaccine at The Palace Nursing & Rehabilitation Center in Miami, Florida on Dec. 29, 2020. Photo: Eva Marie Uzcategui/Bloomberg

To return to some semblance of “normal” after COVID-19 lockdowns, companies are eyeing digital screening platforms to verify someone’s COVID-19 negativity or vaccine status before attending large gatherings. That software may soon come to fruition—and it may not face many barriers to adoption. In fact, lawyers noted that such efforts wouldn’t likely be hindered by data privacy or litigation hurdles so long as they require consent and limit their collection of personally identifiable information (PII). 

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 1 article* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Victoria Hudgins

I am a reporter for Legaltech News, where I cover national and international cyber regulations and legal tech innovations and developments.

More from this author

Law Firms Mentioned


Privacy LawBook

Privacy Law thoroughly explains the legal obligations and potential liability of those who work with and share private information.

Get More Information

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.